Case Report|Articles in Press

A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus


      Fungal otitis externa is a disease encountered occasionally and is caused mostly by Aspergillus or Candida spp. We report a woman with fungal otitis externa who also had typical findings in the external auditory canal. The results of a culture showed coinfection with Candida auris and Aspergillus flavus. Identification of both species was performed by sequencing analysis of the 26S rDNA (D1/D2) and β-tubulin regions. Additionally, the newly developed CHROMagar™ Candida Plus medium was a useful tool for the easy and rapid identification of C. auris. To the best of our knowledge, this is the first report of fungal otitis externa caused by coinfection with C. auris and A. flavus. This case showed good susceptibility to many antifungal drugs and fortunately had a good clinical course with 1% bifonazole cream, which was applied to the fungal coinfection. Notably, C. auris is a multidrug-resistant yeast-like fungus. The increase in drug-resistant fungi and co-infections caused by these pathogens can make the diagnosis and treatment more complex and difficult. To solve these problems, performing rapid and accurate identification and susceptibility testing using chromogenic medium and molecular biological analysis would be useful.



      CCP (CHROMagar™ Candida Plus), CDC (Centers for Disease Control and Prevention), MIC (minimum inhibitory concentration)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Infection and Chemotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kiakojuri K.
        Molecular identification and antifungal susceptibility of yeasts and molds isolated from patients with otomycosis.
        Mycopathologia. 2021; 186: 245-257
        • Chow N.A.
        • Muñoz J.F.
        • Gade L.
        • Berkow E.L.
        • Li X.
        • Welsh R.M.
        • et al.
        Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses.
        mBio. 2020; 11e03364–19
        • Du H.
        • Bing J.
        • Hu T.
        • Ennis C.L.
        • Nobile C.J.
        • Huang G.
        Candida auris: epidemiology, biology, antifungal resistance, and virulence.
        PLoS Pathog. 2020; 16e1008921
        • Satoh K.
        Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.
        Microbiol Immunol. 2009; 53: 41-44
        • Kurtzman C.P.
        • Robnett C.J.
        Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene.
        J Clin Microbiol. 1997; 35: 1216-1223
        • Glass N.L.
        • Donaldson G.C.
        Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes.
        Appl Environ Microbiol. 1995; 61: 1323-1330
        • Narayanan A.
        • Selvakumar P.
        • Siddharthan R.
        • Sanyal K.
        ClaID: a rapid method of clade-level identification of the multidrug resistant human fungal pathogen Candida auris.
        Microbiol Spectr. 2022; 10 (22. Epub 2022 Mar 28)e0063422
        • CDC
        Recommendations for identification of Candida auris.
        • Lockhart S.R.
        Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.
        Clin Infect Dis. 2017; 64: 134-140
        • Gawaz A.
        • Weisel G.
        Mixed infections are a critical factor in the treatment of superficial mycoses.
        Mycoses. 2018; 61: 731-735
        • Sharma C.
        • Kumar N.
        • Meis J.
        • Pandey R.
        • Chowdhary A.
        Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India.
        Genome Announc. 2015; 3e00722–15
        • Iguchi S.
        Candida auris: a pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
        J Infect Chemother. 2019; 25: 743-749
        • CDC
        Recommendations for identification of Candida auris.
        • Mulet Bayona J.V.
        Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples.
        Diagn Microbiol Infect Dis. 2020; 98115168
        • Kordalewska M.
        Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris.
        J Clin Microbiol. 2017; 55: 2445-2452
        • Yamamoto M.
        Rapid detection of Candida auris based on loop-mediated isothermal amplification (LAMP).
        J Clin Microbiol. 2018; 56e00591–18
        • Oh B.J.
        Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea.
        Med Mycol. 2011; 49: 98-102
        • Perlin D.S.
        The global problem of antifungal resistance: prevalence, mechanisms, and management.
        Lancet Infect Dis. 2017; 17: e383-e392